23rd Aug 2019 11:06 am |
RNS |
Director Dealings / Market Share Purchase |
9th Aug 2019 12:00 pm |
RNS |
Notice of Interim Results |
1st Aug 2019 9:18 am |
RNS |
Total Voting Rights |
25th Jul 2019 2:17 pm |
RNS |
Director Dealings / Market Share Purchase |
1st Jul 2019 11:04 am |
EQS |
Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value |
1st Jul 2019 10:01 am |
RNS |
Block listing Interim Review |
1st Jul 2019 9:32 am |
RNS |
Total Voting Rights |
28th Jun 2019 7:00 am |
RNS |
Repayment of Debt Facility |
26th Jun 2019 2:52 pm |
RNS |
Director Dealings / Market Share Purchase |
26th Jun 2019 7:00 am |
RNS |
OXB and Santen enter R&D collaboration |
25th Jun 2019 7:00 am |
RNS |
Board Change |
18th Jun 2019 7:15 am |
EQS |
Hardman & Co Research: Oxford BioMedica (OXB): De-leveraging the balance sheet |
10th Jun 2019 2:34 pm |
RNS |
Director/PDMR Shareholding |
6th Jun 2019 1:08 pm |
RNS |
Axovant update on 1st cohort of Sunrise-PD trial |
6th Jun 2019 11:39 am |
RNS |
Holding(s) in Company |
5th Jun 2019 12:06 pm |
RNS |
Holdings in Company |
4th Jun 2019 5:38 pm |
RNS |
Holdings in Company |
4th Jun 2019 9:59 am |
RNS |
Total Voting Rights |
3rd Jun 2019 6:06 pm |
RNS |
Holding(s) in Company |
3rd Jun 2019 10:31 am |
RNS |
Total Voting Rights |
29th May 2019 6:19 pm |
RNS |
Exercise of Subscription Option by Novo Holdings |
29th May 2019 1:06 pm |
RNS |
Result of AGM |
28th May 2019 7:00 am |
RNS |
Strategic Investment by Novo Holdings A/S |
23rd May 2019 6:04 pm |
RNS |
Director Dealings / Market Share Purchase |
2nd May 2019 2:53 pm |
RNS |
Long Term Incentive Plan Option Grant |
1st May 2019 12:52 pm |
RNS |
REPLACEMENT: Total Voting Rights |
1st May 2019 11:33 am |
RNS |
Total Voting Rights |
30th Apr 2019 5:38 pm |
RNS |
Holdings in Company |
30th Apr 2019 1:35 pm |
RNS |
Oxford Biomedica to present at the ASGCT |
30th Apr 2019 1:15 pm |
RNS |
Axovant doses second cohort of AXO-Lenti-PD |
25th Apr 2019 3:38 pm |
RNS |
Director Dealings / Market Share Purchase |
23rd Apr 2019 1:47 pm |
RNS |
Deferred Bonus Plan and LTIP Option Grants |
23rd Apr 2019 11:38 am |
RNS |
Director Dealings / Market Share Transactions |
18th Apr 2019 5:33 pm |
RNS |
Exercise of warrants |
18th Apr 2019 7:00 am |
RNS |
Annual Report and Accounts & AGM Notification |
1st Apr 2019 11:40 am |
RNS |
Total Voting Rights |
26th Mar 2019 12:57 pm |
RNS |
Director Dealings / Market Share Purchase |
26th Mar 2019 8:25 am |
RNS |
Japanese approval of Kymriah® (tisagenlecleucel) |
14th Mar 2019 7:00 am |
RNS |
Preliminary Results |
12th Mar 2019 7:00 am |
RNS |
OXB announces R&D collaboration with Microsoft |